Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)Headline News about Cidara Therapeutics, Inc. - Common Stock![]() ![]() ![]()
Cidara's Lead Antifungal Candidate Goes Under Priority FDA Review
September 21, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|